cbdMD, Inc. (YCBD)
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Sector: Perfumes, Cosmetics & Other Toilet Preparations
Industry: Drug Manufacturers - Specialty & Generic
cbdMD, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 11.21M shares outstanding
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products.
The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments.
The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Leadership
Bakari Sellers
Director
Bradley Whitford
Chief Accounting Officer, Treasurer & Secretary
Dr. Sibyl Swift
CSO, Vice President of Regulatory Affairs & Director
Jeffrey Porter
Board Member
Employees
42
Country
US
Sector
Healthcare
Website
cbdmd.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 | |
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 | |
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 | |
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 | |
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 | |
| Director | Grant/Award | 1.6K | -- | Apr 14, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Kennedy Thomas Ronan CEO and CFO | 513.7K | 4.6% | FORM 4 |
CRC Investment Fund LP · may incl. warrants· filed Dec 2025 | 361.4K | 3.2% | 13G |
Worth Venture Partners, LLC | 184.8K | 1.6% | 13F |
CSS LLC/IL | 137.6K | 1.2% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 119.6K | 1.1% | 13F |
CHAPIN DAVIS, INC. | 81.3K | 0.7% | 13F |
Chicago Partners Investment Group LLC | 78.1K | 0.7% | 13F |
Porter Jeffrey H · may incl. warrants· filed May 2025 | 71.7K | 0.6% | 13D |
Alesco Advisors, LLC, An ESL Co | 68.5K | 0.6% | 13F |
XTX Topco Ltd | 62.7K | 0.6% | 13F |
Insiders
- Swift Sibyl NicholeDirector
- Roe Kevin CharlesDirector
- Porter Jeffrey HDirector
- Raines William F IIIDirector
- Stephen Scott G.Director
- Sellers Bakari T.Director
- Crosnoe Clark R.10% Owner
- Kennedy Thomas RonanCEO and CFO
based on 11.21M shares outstanding
30d Avg
84.67K
60d Avg
537.61K
90d Avg
407.94K